Magnetic resonance imaging in the differential diagnosis of ovarian masses: Capabilities of quantitative multiparametric evaluation
- 作者: Solopova A.E.1, Makatsaria A.D.1, Sdvizhkov A.M.2, Ternovoy S.K.1
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University
- GBUZ Cancer Clinic № 1 of Moscow Health Department
- 期: 编号 2 (2017)
- 页面: 80-85
- 栏目: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247883
- DOI: https://doi.org/10.18565/aig.2017.2.80-5
- ID: 247883
如何引用文章
详细
全文:
作者简介
Alina Solopova
I.M. Sechenov First Moscow State Medical University
Email: dr.solopova@mail.ru
Candidate of Medicine, assistant professor, Department of radiology and radiotherapy, Faculty of Medicine
Aleksandr Makatsaria
I.M. Sechenov First Moscow State Medical UniversityDoctor of Medicine, Professor, Head of Department of Obstetrics and Gynecology, Faculty of Preventive Medicine
Aleksandr Sdvizhkov
GBUZ Cancer Clinic № 1 of Moscow Health Departmentchief physician of clinical
Sergey Ternovoy
I.M. Sechenov First Moscow State Medical UniversityDoctor of Medicine, Professor, Head of Department of radiology and radiotherapy, Faculty of Medicine
参考
- Каприн А.Д., Старинский В.В., Петрова Г.В., ред. Злокачественные новообразования в России в 2013г (заболеваемость и смертность). М.: МНИОИ им. П.А Герцена - Филиал ФГБУ «ФМИЦ им. П.А Герцена» Минздрава России; 2015. [Kaprin A.D., Starinskiy V.V., Petrova G.V., eds. Malignancies in Russie in 2013 (morbidity and mortality). Moscow: MNIOI them. PA Herzen - Branch FGBI „FMITS them. PA Herzen „Russian Ministry of Health; 2015. (in Russian)]
- Аксель E.M. Статистика злокачественных новообразований женской половой сферы. Онкогинекология. 2012; 1:18-24. [AkselE.M. Statistics of malignant tumors of female genitalia. Onkoginekologiya. 2012; 1: 18-24. (in Russian)]
- Солопова A.E., Чащин A.A., Солопова А.Г., Макацария А.Д. Неоадьювантная терапия рака яичников. Современные возможности и критерии отбора. Акушерство, гинекология и репродукция. 2016; 10(2): 44-54. [Solopova А.Е., Chaschin А.А, Solopova A.G., Makatsariya AD. Neoadjuvant therapy of ovarian cancer. Modern features and selection criteria. Akusherstvo, ginekologiya і reproduktsiya. 2016; 10(2): 44-54. (in Russian)]
- Gömez-Hidalgo N.R., Martinez-Cannon B.A., Nick A.M., Lu КН., Sood A.K., Coleman R.L., Ramirez RT. Predictors of optimal cytoreduction in patients with newly diagnosed advanced-stage epithelial ovarian cancer: time to incorporate laparoscopic assessment into the standard of care. Gynecol. Oncol. 2015; 137(3): 553-8. doi: 10.1016/j.ygyno.2015.03.049.
- Fagö-Olsen C.L., Ottesen B., Kehlet H., Antonsen S.L., Christensen I.J., Markauskas A. et al. Does neoadjuvant chemotherapy impair long-term survival for ovarian cancer patients? A nationwide Danish study. Gynecol. Oncol. 2014; 132(2): 292-8.
- Morgan R.J., Armstrong D.K, Alvarez R.D., Bakkum-Gamez J.N. et al. NCCN Clinical Practice Guidelines in Oncology. Ovarian cancer, including fallopian tube cancer and primary peritoneal cancer. Version 2. 2015. Available at: http://www. tri-kobe.org/nccn/guideline/gynecological/english/ovarian.pdf
- Sala E., DeSouza N., Lee S.I., Atri M., Hricak H.; Gynaecological Cancer InterGroup. Ovarian cancer: the role of functional imaging as an end point in clinical trials. Int. J. Gynecol. Cancer. 2010; 20(6): 971-8. doi: 10.1111/ IGC.0b013e3181e0a353.